Clinical Trial

Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care

Study acronym: DiabOUT
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 8, 2023 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized trial that evaluates the effect of metformin addition or not to standard care on the duration of diabetes remission after bariatric surgery.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-10-05; most recent amendment 2023-06-07.
Status change: Not Yet Recruiting → Recruiting 2021-06-23
Trial Details
NCT Number NCT04581447
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Ministry of Health, France
Conditions Diabetes, Bariatric Surgery, Metformin
Enrollment 126 participants
Start Date 2021-01-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2023-06-08